R F Booth|P F Lott - JoVE Visualize

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Atherosclerosis|April 1, 1989

Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulationR F Booth, J F Martin, A C Honey, et al.

Thrombosis and Haemostasis|April 8, 1988

Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivoN Lad, A C Honey, D O Lunt, et al.

NMR in Biomedicine|April 1, 1990

Lipid characterization in an animal model of atherosclerosis using NMR spectroscopy and imagingR F Booth, A C Honey, J F Martin, et al.

Biochemical Pharmacology|November 15, 1990

A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activityR F Booth, D O Lunt, N Lad, et al.

Journal of Medicinal Chemistry|September 1, 1987

Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitorsP W Manley, N M Allanson, R F Booth, et al.

Platelets|November 4, 2010

5-[6-1 -(Cyclohexyl-1 H-tetrazol-5-YL)hexyl]-1,8-naphthyridin-2-(1H)-one, SC-44368, a Potent Anti-aggregatory Agent which Selectively Inhibits Platelet Cyclic AMP PhosphodiesteraseR F Booth, P W Manley, S P Buckham, et al.

Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Atherosclerosis|April 1, 1989

Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulationR F Booth, J F Martin, A C Honey, et al.

Thrombosis and Haemostasis|April 8, 1988

Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivoN Lad, A C Honey, D O Lunt, et al.

NMR in Biomedicine|April 1, 1990

Lipid characterization in an animal model of atherosclerosis using NMR spectroscopy and imagingR F Booth, A C Honey, J F Martin, et al.

Biochemical Pharmacology|November 15, 1990

A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activityR F Booth, D O Lunt, N Lad, et al.

Journal of Medicinal Chemistry|September 1, 1987

Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitorsP W Manley, N M Allanson, R F Booth, et al.

Platelets|November 4, 2010

5-[6-1 -(Cyclohexyl-1 H-tetrazol-5-YL)hexyl]-1,8-naphthyridin-2-(1H)-one, SC-44368, a Potent Anti-aggregatory Agent which Selectively Inhibits Platelet Cyclic AMP PhosphodiesteraseR F Booth, P W Manley, S P Buckham, et al.

Pageof 4